XNYS · Healthcare Plans
Last stored close · Sep 18, 2026
Close · Sep 18, 2026
$386.22+0.44%
Model Target
available with Pro
Implied upside
vs the model target
Valuation methods
the methods behind the target
TickerWhale Score
51/100
Moderate
Score components
TickerWhale View
Humana scores 51 out of 100 overall, which we rate moderate. Technical is its strongest area and Valuation its weakest.
What helps
- Technical
- Quality & growth
- Sentiment Signal
What to watch
- Valuation
- Risk
Quality & growth
30%67Positive
- Revenue growth 18.5%
- EPS growth -18.8%
Valuation
25%11Weak
- P/E 36.6
- EV/Sales 0.4
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
#259 by market cap in our coverage · ~67,060 employees · Listed 1971-05-18 · www.humana.com
Price history
Intraday to five-year windows are free with an account
Members switch between 1D, 1M, 6M, 1Y, 2Y and 5Y and see the live price. Signed out, this is the one-year stored series the technicals below are computed from.
Market intelligence
Peer position
#91 / 139sector rank by TickerWhale Score
TickerWhale Score 51 vs sector average 55.1 (-4.1)
Revenue growth (industry)Top 25%
Gross margin (industry)Top 75%
Return on equity (industry)Top 63%
P/E (industry)Pricier than 83%
Technical analysis
our read · what classic indicators sayTickerWhale technical read
79/100Strong vs universe
Ranks 79th of 100 covered names on our technical composite — the composite itself scores 63/100 · 25% of the TickerWhale Score
Classic chart indicators
Sell
2 buy · 4 sell · 2 neutral of 8 votes
TickerWhale rates HUM's technical setup strong — 79th percentile of the covered universe. Classic chart indicators lean sell — they read this stock on its own over days, where our score ranks it against every covered name over months, so the two often part company.
Moving averages
4 / 9constructive
- vs 200-day+34.6%
- vs 50-day-0.6%
Momentum
Mixed
- RSI (14)46 · neutral
- Stochasticbuy
- CCIneutral
- Williams %Rbuy
Trend
Weak
- ADX (14) trend strength26· trending
- MACD (12,26,9)sell(histogram -2.116)
How the classic verdict is reached
Moving averages (9) agree on sell — 4 buy vs 5 sell — and carry one vote between them.
Oscillators (7) vote individually: 2 buy · 3 sell · 2 neutral.
Result — 2 buy vs 4 sell of 8 votes = Sell. Neutral votes never decide the verdict.
Fundamentals & valuation
2026-09-18 · revised_latestValuation multiples
- P/E (TTM)36.6
- P/S (TTM)0.3
- P/B2.4
- EV/EBITDA—
- EV/Sales0.4
- PEG—
Profitability & returns
- Gross margin13.3%
- Net margin0.9%
- ROE6.8%
- Debt/Equity0.74
Growth
- Revenue growth (YoY)18.5%
- EPS growth (YoY)-18.8%
Green favourable · red stretched — multiples and D/E vs industry peers, margins and growth vs absolute thresholds.
Market capitalisation — $46.8B
Fundamentals history
Reported statement totals across recent periods.
Fundamentals are stored revised/latest (ADR-009): each period reflects the most recent vendor refresh, NOT point-in-time as-reported values. Do not use this series to claim what was known on a past date.
Model Target
Model Target is a Pro feature
Scores, factors and technicals stay free. The model's price target is part of TickerWhale Pro.
The Model Target is a TickerWhale Pro feature
A target exists for this name — the model priced it in the latest nightly run. Pro members see the target, its range and the methods behind it; one name's target is free every trading day.
Or see the current free one: MU →
Peers
| Company | Score | Pulse | P/E | P/E fwd | P/B | EV/Sales | Price | Chg | Estimate | Upside | Rev. gr. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HUMCurrentHumana | 51 | 63 | 36.6 | — | 2.4 | 0.4 | $386.22 | +0.44% | +18.5% | ||
| EXELExelixis | 81 | 80 | 17.6 | — | 8.2 | 6.1 | $58.36 | -0.22% | +9.2% | ||
| INCYIncyte | 81 | 76 | 16.2 | — | 4.1 | 3.8 | $125.31 | -1.81% | +26.9% | ||
| ACADAcadia Pharmaceuticals | 80 | 63 | 12.4 | — | 3.6 | 3.8 | $27.29 | -0.58% | +11.8% | ||
| OSCROscar Health Inc - | 78 | 67 | 19.5 | — | 5.2 | 0.5 | $32.13 | +0.47% | +43.1% | ||
| TGTXTG Therapeutics | 77 | 73 | 20.3 | — | 14.8 | 11.5 | $56.87 | +0.71% | +76.1% |
News, sentiment, the Street view and Ask Willy are free with an account
A free account shows the stories attached to this name, the Sentiment Signal breakdown, analyst consensus, the options read and the AI narration of the model output.